NO20020291D0 - Preventive og terapeutiske midler for kreft - Google Patents

Preventive og terapeutiske midler for kreft

Info

Publication number
NO20020291D0
NO20020291D0 NO20020291A NO20020291A NO20020291D0 NO 20020291 D0 NO20020291 D0 NO 20020291D0 NO 20020291 A NO20020291 A NO 20020291A NO 20020291 A NO20020291 A NO 20020291A NO 20020291 D0 NO20020291 D0 NO 20020291D0
Authority
NO
Norway
Prior art keywords
preventive
cancer
therapeutic agents
therapeutic
agents
Prior art date
Application number
NO20020291A
Other languages
English (en)
Other versions
NO20020291L (no
Inventor
Shinichi Kurakata
Kosaku Fujiwara
Takashi Fujita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20020291D0 publication Critical patent/NO20020291D0/no
Publication of NO20020291L publication Critical patent/NO20020291L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
NO20020291A 1999-07-19 2002-01-18 Terapeutiske og profylaktiske midler for neoplasmer NO20020291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20447699 1999-07-19
PCT/JP2000/004858 WO2001005402A1 (fr) 1999-07-19 2000-07-19 Agents preventifs et therapeutiques du cancer

Publications (2)

Publication Number Publication Date
NO20020291D0 true NO20020291D0 (no) 2002-01-18
NO20020291L NO20020291L (no) 2002-03-18

Family

ID=16491170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020291A NO20020291L (no) 1999-07-19 2002-01-18 Terapeutiske og profylaktiske midler for neoplasmer

Country Status (18)

Country Link
US (1) US6569877B2 (no)
EP (1) EP1197211A4 (no)
KR (1) KR20020015383A (no)
CN (1) CN1374864A (no)
AU (1) AU760917B2 (no)
BR (1) BR0012591A (no)
CA (1) CA2379662A1 (no)
CZ (1) CZ2002178A3 (no)
HU (1) HUP0202340A3 (no)
IL (1) IL147593A0 (no)
MX (1) MXPA02000757A (no)
NO (1) NO20020291L (no)
NZ (1) NZ516636A (no)
PL (1) PL352681A1 (no)
RU (1) RU2219928C2 (no)
TR (1) TR200200111T2 (no)
WO (1) WO2001005402A1 (no)
ZA (1) ZA200200316B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
US9092523B2 (en) 2005-02-28 2015-07-28 Search Engine Technologies, Llc Methods of and systems for searching by incorporating user-entered information
KR101532715B1 (ko) 2005-03-18 2015-07-02 써치 엔진 테크놀로지스, 엘엘씨 서치 결과를 향상시키기 위해 사용자로부터의 피드백을 적용하는 서치 엔진
WO2007100027A1 (ja) * 2006-03-02 2007-09-07 Daiichi Sankyo Company, Limited 光学活性なチアゾリジンジオン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3152992B2 (ja) * 1992-04-03 2001-04-03 株式会社興人 過酸化脂質の生成抑制及び消去用組成物
DK0805155T3 (da) * 1994-09-28 2002-07-08 Nippon Suisan Kaisha Ltd Hidtil ukendt tricyklisk, kondenseret heterocyklisk antioxidantforbindelse
JP3820601B2 (ja) * 1995-03-27 2006-09-13 大塚製薬株式会社 活性酸素消去剤
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
CZ302475B6 (cs) * 1997-10-08 2011-06-08 Sankyo Company Limited Substituované kumulované heterocyklické slouceniny
AU1507799A (en) * 1997-12-16 1999-07-05 Sankyo Company Limited Leukemia remedy
US6878896B2 (en) * 2002-07-24 2005-04-12 United Parcel Service Of America, Inc. Synchronous semi-automatic parallel sorting

Also Published As

Publication number Publication date
CZ2002178A3 (cs) 2002-05-15
IL147593A0 (en) 2002-08-14
BR0012591A (pt) 2002-04-09
CN1374864A (zh) 2002-10-16
EP1197211A1 (en) 2002-04-17
US6569877B2 (en) 2003-05-27
AU760917B2 (en) 2003-05-22
RU2219928C2 (ru) 2003-12-27
PL352681A1 (en) 2003-09-08
MXPA02000757A (es) 2002-07-22
WO2001005402A1 (fr) 2001-01-25
NZ516636A (en) 2004-01-30
CA2379662A1 (en) 2001-01-25
HUP0202340A3 (en) 2006-03-28
US20020137776A1 (en) 2002-09-26
NO20020291L (no) 2002-03-18
TR200200111T2 (tr) 2002-08-21
ZA200200316B (en) 2003-06-25
HUP0202340A2 (hu) 2003-02-28
EP1197211A4 (en) 2004-09-01
AU6021200A (en) 2001-02-05
KR20020015383A (ko) 2002-02-27

Similar Documents

Publication Publication Date Title
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DK1566200T3 (da) Illuminator til fotodynamisk terapi
DK1637127T3 (da) Terapeutisk mikroskum
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
NO20022656D0 (no) Caspaseinhibitorer og anvendelse derav
NO20021400D0 (no) Terapeutiske konazolinderivater
NO20000996D0 (no) Kombinasjonsterapi omfattende atorvastatin og et antihypertensivt middel
IS2277B (is) Meðferðarlegar bíarýl afleiður
DE60019912D1 (de) Schütz
NO20022692D0 (no) Terapeutiske midler
PL349355A1 (en) Diaryl derivatives and their application as therapeutic agents
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20010487D0 (no) Disubstituert maleimidforbindelse og farmasöytisk anvendelse herav
NO20005179D0 (no) Medikament behandling
IS2841B (is) Samstæða hluta og lyfjasamsetningar
DE60019864D1 (de) Lasertherapiegerät
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
NO20021011D0 (no) Fremgangsmåte og formulering for tumorremisjon og suppresjon av cancer
DE60003114D1 (de) Laserbehandlungsvorrichtung
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO20020291D0 (no) Preventive og terapeutiske midler for kreft
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
EP1259255A4 (en) PAI-2 CONJUGATES FOR THE TREATMENT AND VISUALIZATION OF CANCERS
NO20016301D0 (no) Terapeutiske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application